Suppr超能文献

相似文献

2
Microfluidic-Based Holonomic Constraints of siRNA in the Kernel of Lipid/Polymer Hybrid Nanoassemblies for Improving Stable and Safe In Vivo Delivery.
ACS Appl Mater Interfaces. 2020 Apr 1;12(13):14839-14854. doi: 10.1021/acsami.9b22781. Epub 2020 Mar 20.
3
Microfluidic platform for controlled synthesis of polymeric nanoparticles.
Nano Lett. 2008 Sep;8(9):2906-12. doi: 10.1021/nl801736q. Epub 2008 Jul 26.
4
Microfluidic Nanoparticles for Drug Delivery.
Small. 2022 Sep;18(36):e2106580. doi: 10.1002/smll.202106580. Epub 2022 Apr 9.
5
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17.
6
Microfluidic technologies for nanoparticle formation.
Lab Chip. 2022 Feb 1;22(3):512-529. doi: 10.1039/d1lc00812a.
7
Microfluidic-assisted polymer-protein assembly to fabricate homogeneous functionalnanoparticles.
Mater Sci Eng C Mater Biol Appl. 2020 Jun;111:110768. doi: 10.1016/j.msec.2020.110768. Epub 2020 Feb 22.
9
Assembly of Fluorescent Polymer Nanoparticles Using Different Microfluidic Mixers.
Langmuir. 2022 Jul 5;38(26):7945-7955. doi: 10.1021/acs.langmuir.2c00534. Epub 2022 Jun 22.

引用本文的文献

2
Lipid-Polymer Hybrid Nanoparticles as a Smart Drug Delivery System for Peptide/Protein Delivery.
Pharmaceutics. 2025 Jun 19;17(6):797. doi: 10.3390/pharmaceutics17060797.
3
On-Chip De Novo Production of mRNA Vaccine in Lipid Nanoparticles.
Small. 2025 Aug;21(32):e2500114. doi: 10.1002/smll.202500114. Epub 2025 Jun 23.
5
Antibody-Nanoparticle Conjugates in Therapy: Combining the Best of Two Worlds.
Small. 2025 Apr;21(15):e2409635. doi: 10.1002/smll.202409635. Epub 2025 Mar 6.
6
A perspective of lipid nanoparticles for RNA delivery.
Exploration (Beijing). 2024 Apr 15;4(6):20230147. doi: 10.1002/EXP.20230147. eCollection 2024 Dec.
7
Lipid polymer hybrid nanoparticles against lung cancer and their application as inhalable formulation.
Nanomedicine (Lond). 2024;19(25):2113-2133. doi: 10.1080/17435889.2024.2387530. Epub 2024 Aug 15.
8
Nanoparticles (NPs)-mediated lncMALAT1 silencing to reverse cisplatin resistance for effective hepatocellular carcinoma therapy.
Front Pharmacol. 2024 Jul 30;15:1437071. doi: 10.3389/fphar.2024.1437071. eCollection 2024.
10
Nanotechnology-based delivery systems to overcome drug resistance in cancer.
Med Rev (2021). 2024 Feb 20;4(1):5-30. doi: 10.1515/mr-2023-0058. eCollection 2024 Feb.

本文引用的文献

2
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
ACS Nano. 2008 Aug;2(8):1696-702. doi: 10.1021/nn800275r.
3
Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups.
Biomaterials. 2009 Apr;30(12):2231-40. doi: 10.1016/j.biomaterials.2009.01.005. Epub 2009 Jan 23.
4
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
Biomaterials. 2009 Mar;30(8):1627-34. doi: 10.1016/j.biomaterials.2008.12.013. Epub 2008 Dec 25.
5
Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery.
Angew Chem Int Ed Engl. 2008;47(38):7284-8. doi: 10.1002/anie.200801810.
6
Microfluidic platform for controlled synthesis of polymeric nanoparticles.
Nano Lett. 2008 Sep;8(9):2906-12. doi: 10.1021/nl801736q. Epub 2008 Jul 26.
7
Nanocarriers as an emerging platform for cancer therapy.
Nat Nanotechnol. 2007 Dec;2(12):751-60. doi: 10.1038/nnano.2007.387.
8
Biopolymer microparticle and nanoparticle formation within a microfluidic device.
Langmuir. 2008 Jun 1;24(13):6937-45. doi: 10.1021/la703339u. Epub 2008 May 30.
9
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers.
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2586-91. doi: 10.1073/pnas.0711714105. Epub 2008 Feb 13.
10
Characterization of nanoparticles for therapeutics.
Nanomedicine (Lond). 2007 Dec;2(6):789-803. doi: 10.2217/17435889.2.6.789.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验